DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Desnick RJ.
Enzyme replacement therapy for Fabry disease: lessons from two alpha-galactosidase A orphan products and one FDA approval.
Expert Opin Biol Ther 2004; 4: 1167-1176
We do not assume any responsibility for the contents of the web pages of other providers.